These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Kaufmann O; Dietel M Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746 [TBL] [Abstract][Full Text] [Related]
4. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung. Argon A; Nart D; Veral A Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390 [TBL] [Abstract][Full Text] [Related]
5. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Srodon M; Westra WH Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164 [TBL] [Abstract][Full Text] [Related]
7. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541 [TBL] [Abstract][Full Text] [Related]
8. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study]. Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300 [TBL] [Abstract][Full Text] [Related]
9. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132 [TBL] [Abstract][Full Text] [Related]
10. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Afify AM; al-Khafaji BM Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029 [TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material. Sathiyamoorthy S; Maleki Z Diagn Cytopathol; 2014 Jan; 42(1):5-10. PubMed ID: 23637102 [TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical detection of TTF-1 in intraoperative bioptic samples of adenocarcinoma of the lung: a year-long experience]. Matej R; Vedralová J; Koukolík F Cesk Patol; 2008 Apr; 44(2):41-4. PubMed ID: 18819326 [TBL] [Abstract][Full Text] [Related]
15. KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis. Takanashi Y; Tajima S; Hayakawa T; Neyatani H; Funai K Int J Clin Exp Pathol; 2015; 8(11):15338-43. PubMed ID: 26823891 [TBL] [Abstract][Full Text] [Related]
16. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Zamecnik J; Kodet R Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. Abutaily AS; Addis BJ; Roche WR J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995 [TBL] [Abstract][Full Text] [Related]
18. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
19. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515 [TBL] [Abstract][Full Text] [Related]
20. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]